Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

TSP-1 antiangiogenic gene therapy and its application in prostate cancer

Feb. 13, 2001

Licensing opportunity from NIH: viral chemokine-antigen fusion proteins

Feb. 13, 2001

Licensing opportunity from NIH: defensin-tumor antigen fusions

Feb. 13, 2001

Heterocyclic inhibitors of tyrosine kinase-mediated signal transduction

Feb. 12, 2001

Antisense modulators of integrin beta3 expression

Feb. 12, 2001

Isis designs antisense oligonucleotides that modulate the expression of G-proteins

Feb. 12, 2001

First oral chemotherapy for treatment of metastatic colorectal cancer approved in Europe

Feb. 12, 2001

Licensing opportunity from NIH: acridine derivative for overcoming MDR

Feb. 12, 2001

ISIS-28030: a new antisense inhibitor of PI3K p85

Feb. 9, 2001

Phase III trial of irofulven in pancreatic cancer proceeds on schedule

Feb. 9, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...